Xeomin (incobotulinumtoxinA) is the purified, naked botulinum toxin, filtered to remove the complexing proteins other brands carry. Learn how it works, what it treats, results, safety, cost, and how it compares to Botox, Dysport, and Daxxify.
Xeomin (incobotulinumtoxinA) is a prescription botulinum toxin type A injectable that temporarily relaxes facial muscles to soften frown lines. Made by Merz, it is the purified or naked neurotoxin, filtered to remove the complexing proteins other brands carry. Results appear in three to five days and last about three to four months.
Xeomin is one of the four major botulinum toxin brands used in aesthetics, alongside Botox, Dysport, and Daxxify. It does the same job as the others: injected in tiny, controlled doses, it temporarily quiets the nerve signals that make specific muscles contract, so the skin over those muscles stops creasing and dynamic wrinkles soften. What sets Xeomin apart is not what it does but what is left out of the vial. It is the only widely available toxin stripped of the accessory proteins that surround the active molecule in other products, which is why it is nicknamed the naked toxin. This guide explains what Xeomin actually is, how it works, what it treats, what a session feels like, how long results last, the real risks, how it compares to its rivals, what it costs, and how to decide whether it is right for you.
FDA status note: Xeomin is FDA-approved for moderate to severe glabellar (frown) lines in adults and for several neurological and medical conditions. Common aesthetic uses beyond the frown lines, such as forehead lines, crow's feet, the masseter, and a lip flip, are off-label, meaning the FDA has not formally cleared Xeomin for those areas even though injectors use it there routinely. This article is educational and is not a substitute for a consultation with a licensed medical provider.
**Xeomin is the brand name for incobotulinumtoxinA, a prescription injectable made from botulinum toxin type A, the same protein family used in Botox, Dysport, and Daxxify.** It is manufactured by Merz Pharmaceuticals and comes as a sterile, freeze-dried powder that the injector reconstitutes with saline before treatment. Like every product in this class, it is a neuromodulator: it does not fill or plump anything, it temporarily relaxes the muscle it is placed in.
The detail that defines Xeomin sits in its full chemical name. Botulinum toxin type A, as it exists in nature, travels bundled inside a cluster of accessory or complexing proteins. Botox and Dysport keep some of those proteins in the finished drug. Xeomin is put through an extra purification step that removes them, leaving only the roughly 150-kilodalton active neurotoxin. That is the naked in naked toxin. In practical terms it means a smaller, cleaner molecule with nothing riding along that the immune system might learn to recognize.
Xeomin has been available in the United States since 2010 for medical use and since 2011 for cosmetic frown lines, and it has a longer track record in Europe, where Merz first launched it in 2005. It is a genuine, established alternative rather than a new or experimental product, and for many patients it is chosen precisely because of the purified formulation described below.
**Xeomin works by blocking the chemical messenger that tells a muscle to contract.** Normally, a nerve ending releases a neurotransmitter called acetylcholine, which crosses the tiny gap to the muscle and triggers it to tighten. Xeomin binds to the nerve ending and prevents that release. With no signal arriving, the treated muscle cannot fully contract, so it relaxes.
When the muscle underneath relaxes, the skin on top stops folding every time you make an expression. That is why toxins target dynamic wrinkles, the lines that appear when you frown, squint, or raise your eyebrows, rather than static lines that are etched in at rest. Over time, softening a repeatedly creased area can also help the resting line look shallower, because the skin is no longer being folded thousands of times a day.
The effect is temporary and local. Xeomin only affects the specific muscles it is injected into, and it does not touch sensation, so the treated area still feels normal even though it moves less. The block is not permanent because the nerve gradually sprouts new endings and re-establishes contact with the muscle, at which point movement, and eventually the wrinkle, returns. This is the same mechanism shared by Botox, Dysport, and Daxxify. Once inside the muscle, a purified toxin and a protein-wrapped toxin behave the same way. The purification changes the immune conversation, not the muscle biology.
The complexing proteins removed from Xeomin serve no therapeutic purpose once the drug is injected. They exist to protect the toxin inside the bacterium and during manufacturing, and they separate from the active molecule within minutes of an injection anyway. Their main consequence is immunological: they give the immune system extra material to potentially react against.
The theoretical advantage of stripping them out is a lower chance of forming neutralizing antibodies, the antibodies that can make a toxin gradually stop working, a phenomenon sometimes called secondary non-response or toxin resistance. Because Xeomin presents the immune system with less foreign protein, several researchers have argued it carries a lower immunogenic potential. This matters most for people who receive frequent, high-dose treatment, such as patients treated for cervical dystonia or spasticity, and it is a smaller consideration for someone getting a modest cosmetic dose two or three times a year. For most aesthetic patients, resistance is uncommon with any modern toxin, so the purified formulation is a reassuring feature rather than a dramatic one.
The naked formulation carries one more practical perk. Xeomin is stable at room temperature before it is reconstituted, so it does not require refrigeration for storage the way some toxins traditionally have. That is a convenience for the clinic rather than a benefit you will feel, but it reflects the same underlying point: fewer proteins, a more robust and predictable product.
**In aesthetics, Xeomin's only FDA-approved cosmetic indication is moderate to severe glabellar lines, the vertical frown lines between the eyebrows often called the 11s.** That is the use it was studied and cleared for in cosmetic patients. Many other popular facial uses are off-label, which is legal and common but means the FDA has not formally reviewed Xeomin for those areas.
Off-label aesthetic uses include horizontal forehead lines, crow's feet at the outer corners of the eyes, a lip flip to gently roll the upper lip, softening the chin, relaxing vertical neck bands, and shrinking the masseter muscle for jaw slimming or teeth-grinding relief. These are well-established injector techniques, and off-label does not mean unsafe or unproven. It means the manufacturer did not pursue a separate FDA study for that specific spot. A trustworthy provider will tell you plainly which part of your treatment is on-label and which is off-label.
Xeomin also carries a robust set of FDA-approved medical indications that are worth knowing, because they show the drug is well characterized. These include cervical dystonia (a neck-muscle disorder), blepharospasm (involuntary eyelid spasms), upper limb spasticity in adults and in children two years and older, and chronic sialorrhea (severe drooling) in adults and children. Those medical uses are handled by neurologists and specialists, not medspas, but they are part of why Xeomin has a deep safety and dosing record.
**A Xeomin session is quick, in-office, and requires no anesthesia or downtime.** It starts with a consultation in which the injector watches your face move, marks the muscles driving your lines, and agrees on a plan and a unit count with you. Because dosing is measured in units rather than volume, the exact number depends on your muscle strength and how many areas you are treating, not on a fixed amount.
The injection itself takes only a few minutes. The provider reconstitutes the powder with saline, draws it into a very fine needle, and places small amounts into the targeted muscles. Most people describe the sensation as a quick pinch or sting at each point. A typical frown-line treatment involves only a handful of injections. Numbing cream or ice can be used for comfort, though many patients skip it.
Afterward you can return to normal activity almost immediately. Standard aftercare is simple: stay upright for about four hours, avoid rubbing or massaging the treated area so the toxin stays where it was placed, skip strenuous exercise, saunas, and alcohol for the rest of the day, and hold off on facials or lying face-down for a while. You may see tiny bumps or minor redness at the injection points that fade within an hour or two, and small bruises are possible. There is no bandage, no recovery period, and no need to take time off, which is why toxin appointments are often called lunchtime treatments.
**Xeomin typically starts working in three to five days, reaches its full effect at around two weeks, and lasts about three to four months.** The onset is gradual by design, not instant, so the change looks natural rather than sudden. Because the peak takes roughly two weeks, injectors usually wait that long before assessing the result or adding a small touch-up.
A common question is whether Xeomin wears off faster or lasts a shorter time than Botox. The honest answer, supported by comparative clinical work, is no. Xeomin and Botox have a very similar duration, and the removal of complexing proteins does not shorten how long the effect lasts. Duration is driven by your dose, the area treated, your metabolism, and your muscle strength, not by the naked formulation. People with fast metabolisms, strong muscles, or very active expressions may notice movement returning a little sooner, while lighter doses in less mobile areas can linger.
As the effect fades, movement gradually returns and the wrinkle reappears. Xeomin does not cause lines to come back worse than before. Some patients find that with consistent, spaced-out treatments over time, they can maintain results with slightly less product, because the muscle is trained to stay more relaxed. There is no guaranteed result, and individual response varies, which is why an experienced injector and a realistic plan matter more than the brand on the vial.
**For healthy adults treated by a qualified, licensed injector, Xeomin has a strong safety record backed by years of cosmetic and medical use.** Most side effects are mild, temporary, and tied to the needle rather than the drug: small bruises, pinpoint redness, mild swelling, or a short-lived headache. These resolve on their own within hours to a few days.
The effects people worry about come from the toxin spreading beyond or being placed slightly off the intended muscle, not from the medicine itself being dangerous at cosmetic doses. A brow or eyelid can droop temporarily (ptosis) if product migrates, an eyebrow can sit unevenly, or a smile can look asymmetric. These are dose- and placement-dependent, they are temporary, and they resolve as the effect wears off over several weeks. Choosing an experienced injector who understands facial anatomy is the single biggest factor in avoiding them.
Xeomin carries the same FDA boxed warning as all botulinum toxins about the rare possibility of the toxin spreading from the injection site, which in very rare cases can cause muscle weakness, trouble swallowing, or breathing difficulty. At cosmetic doses this is extremely uncommon, but any such symptoms after treatment warrant immediate medical attention. Xeomin is not recommended during pregnancy or breastfeeding, or for people with certain neuromuscular disorders such as myasthenia gravis or ALS, or those with a known allergy to botulinum toxin. Honest candidacy screening, in which the provider reviews your health history before injecting, protects you more than any single product feature.
**Xeomin, Botox, Dysport, and Daxxify are all botulinum toxin type A and relax muscles the same way, so the differences between them are about formulation, dosing scale, and price rather than a large gap in results.** The choice usually comes down to your injector's preference, your history with a product, and cost, not a clear winner.
Against Botox, the practical takeaways are simple. Xeomin dosing is roughly one-to-one with Botox, meaning 20 units of Xeomin is broadly equivalent to 20 units of Botox for the same area, so it is not stronger or weaker in a meaningful sense. Onset and duration are comparable. Xeomin's distinguishing feature is the purified, protein-free formulation, while Botox offers the longest track record and the widest set of FDA-cleared cosmetic areas. Dysport uses a different, non-interchangeable unit scale (its units are not one-to-one with Xeomin or Botox), tends to diffuse a little more, and can kick in slightly faster. Daxxify is the newest and is marketed for potentially longer duration in some patients. For a first-time patient treating frown lines, any of these in skilled hands can produce an excellent, natural result.
| Attribute | Xeomin | Botox | Dysport | Daxxify |
|---|---|---|---|---|
| Active ingredient | incobotulinumtoxinA | onabotulinumtoxinA | abobotulinumtoxinA | daxibotulinumtoxinA |
| Complexing proteins | None (naked) | Yes | Yes | None (peptide-stabilized) |
| Unit scale vs Botox | Roughly 1:1 | Reference | Different (approx 2.5-3:1) | Roughly 1:1 |
| Onset | 3-5 days | 3-5 days | 2-4 days | 1-3 days |
| Typical duration | 3-4 months | 3-4 months | 3-4 months | 4-6 months (claimed) |
| FDA cosmetic indication | Glabellar (frown) lines | Frown, forehead, crow's feet | Glabellar (frown) lines | Glabellar (frown) lines |
**Xeomin is usually priced per unit, commonly in the range of roughly 9 to 16 US dollars per unit, and is often a little cheaper per unit than Botox.** Some clinics instead price by treatment area. Because it is a cosmetic treatment, it is not covered by insurance, and prices vary widely by region, by the provider's experience, and by how many units your muscles need.
Because so many searches ask about a specific dose, here is a realistic frame. Twenty units of Xeomin, a common amount for a single area such as the frown lines, typically runs somewhere around 180 to 320 US dollars in many markets, though metropolitan clinics and highly credentialed injectors can charge more. Stronger muscles, deeper lines, or treating several areas at once will require more units and raise the total. Treat any single quoted figure as an estimate rather than a promise, since real pricing depends on your provider and location.
It is worth resisting the urge to shop on per-unit price alone. Very low pricing can signal over-diluted product, an underdosed treatment that fades fast, or an inexperienced injector. Since injector skill drives both how natural the result looks and how long it lasts, the value equation is about the person holding the needle at least as much as the number on the vial. Many clinics run occasional package pricing or loyalty programs, which can make consistent maintenance more affordable without cutting corners on quality.
**Xeomin is a strong choice if you want a purified, minimal-formulation toxin, if you have developed or worry about resistance to another brand, or if you simply want an established Botox alternative that often costs a little less.** It suits healthy adults looking to soften dynamic frown lines and, off-label, other upper-face and lower-face expression lines. It is not appropriate during pregnancy or breastfeeding, or for people with certain neuromuscular conditions or a botulinum toxin allergy.
For a first-timer with no history of resistance, the difference between Xeomin and Botox in the mirror will usually be negligible, so do not agonize over the brand. What matters far more is the injector. Look for a licensed medical professional, a board-certified dermatologist or plastic surgeon, or a qualified nurse injector or physician assistant working under proper medical supervision, who assesses your facial movement, explains what is on-label and off-label, quotes units transparently, and sets realistic expectations rather than promising a frozen or guaranteed look.
A good consultation should feel like a conversation about your anatomy and goals, not a sales pitch. Ask how many units they recommend and why, what to expect at two weeks, and what their touch-up policy is. When you are ready, the most important step is finding a vetted, experienced injector near you who offers Xeomin and can tailor the dose to your face.
Neither is universally better; they are comparable. Xeomin's edge is its purified naked formulation with no complexing proteins, which may lower the chance of resistance with frequent high-dose use, and it is often slightly cheaper. Botox has the longest track record and more FDA-cleared cosmetic areas. For most people, results look clinically similar.
Yes, roughly. Xeomin and Botox use a nearly one-to-one unit scale, so 20 units of Xeomin is broadly equivalent to 20 units of Botox for the same area. This is unlike Dysport, which uses a different, non-interchangeable unit scale. Your injector fine-tunes the dose to your muscle strength.
No. Xeomin lasts about the same three to four months as Botox. Duration is driven by your dose, the area, your metabolism, and muscle strength, not by removing the complexing proteins. If a result fades quickly, dose or technique is usually the reason, not the brand.
Commonly around 180 to 320 US dollars, at roughly 9 to 16 dollars per unit, often a touch less than Botox. Prices vary widely by region, clinic, and injector experience, and deeper lines or stronger muscles may need more units. Treat any single figure as an estimate, not a fixed price.
Not in a meaningful way. Because Xeomin and Botox dose roughly one-to-one, the same number of units delivers comparable strength for the same area. Xeomin is not a more potent toxin; its distinction is purity, not power. Perceived differences usually come from dosing and injector technique.